CPAP versus Oxygen in Obstructive Sleep Apnea
Author(s) -
Daniel J. Gottlieb,
Naresh M. Punjabi,
Reena Mehra,
Sanjay R. Patel,
Stuart F. Quan,
Denise C. Babineau,
Russell P. Tracy,
Michael Rueschman,
Roger S. Blumenthal,
Eldrin F. Lewis,
Deepak L. Bhatt,
Susan Redline
Publication year - 2014
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1306766
Subject(s) - medicine , obstructive sleep apnea , continuous positive airway pressure , hypoxemia , blood pressure , sleep apnea , randomization , randomized controlled trial , polysomnography , sleep study , apnea , anesthesia
Obstructive sleep apnea is associated with hypertension, inflammation, and increased cardiovascular risk. Continuous positive airway pressure (CPAP) reduces blood pressure, but adherence is often suboptimal, and the benefit beyond management of conventional risk factors is uncertain. Since intermittent hypoxemia may underlie cardiovascular sequelae of sleep apnea, we evaluated the effects of nocturnal supplemental oxygen and CPAP on markers of cardiovascular risk.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom